New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
07:47 EDTMYGN, LHMyriad Genetics participation pacts to be terminated by NJ Horizon Blue Cross
Horizon Blue Cross Blue Shield of New Jersey, an independent licensee of the Blue Cross and Blue Shield Association, announced yesterday that it is terminating its participation agreements with Myriad Genetics (MYGN), effective June 15 for patients enrolled in Horizon BCBSNJ managed care plans and effective July 3 for patients enrolled in Horizon BCBSNJ PPO and Indemnity plans. Following the terminations of Myriad Genetics, LabCorp (LH) will be the only participating clinical laboratory to provide BRCA-specific genetic testing for Horizon BCBSNJ patients, the insurer noted. Reference Link
News For MYGN;LH From The Last 14 Days
Check below for free stories on MYGN;LH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
08:04 EDTLHLabCorp, ARCA Biopharma present GENETIC-AF poster at HFSoA meeting
Subscribe for More Information
September 15, 2014
07:21 EDTLHHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 9, 2014
07:11 EDTMYGNMyriad Genetics presented results from myPath Melanoma test clinical study
Subscribe for More Information
September 8, 2014
08:36 EDTLHARCA Biopharma, LabCorp announce GENETIC-AF poster presentation
Subscribe for More Information
September 3, 2014
16:14 EDTMYGNMyriad Genetics says myRisk test improves detection of cancer-causing mutations
Myriad Genetics announced that the Myriad myRisk Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46% in patients with breast cancer in a new study published in the journal Cancer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use